Download PDF
Thromb Haemost 1999; 82(01): 88-92
DOI: 10.1055/s-0037-1614634
Rapid Communication
Schattauer GmbH

Role of Tissue Factor in Metastasis: Functions of the Cytoplasmic and Extracellular Domains of the Molecule

Michael E. Bromberg
1   From the Yale University, School of Medicine, Department of Internal Medicine, New Haven, CT
,
Ranjini Sundaram
2   From the Yale University, Department of Molecular Biophysics and Biochemistry, New Haven, CT
,
Robert J. Homer
3   From the Yale University, Department of Pathology, New Haven, CT, USA
,
Alan Garen
2   From the Yale University, Department of Molecular Biophysics and Biochemistry, New Haven, CT
,
William H. Konigsberg
2   From the Yale University, Department of Molecular Biophysics and Biochemistry, New Haven, CT
› Author AffiliationsThe skilled technical assistance of Michelle Bailly and discussions with Drs. J. Madison-McNiff and J. Concato are gratefully acknowledged. This research received support from NCI grant K11-CA64205 (MEB), Junior Faculty Research Award from Yale University Department of Internal Medicine (MEB) and U.S. Public Health Services Grant PO1-HL 29019 (WHK).
Further Information

Publication History

Received 15 December 1998

Accepted after revision 11 March 1999

Publication Date:
11 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

Tissue factor (TF) is a transmembrane glycoprotein that complexes with factor VIIa to initiate blood coagulation. It was reported in an earlier study that expression of high levels of TF in a human melanoma cell line promotes metastasis, and that the cytoplasmic domain of TF is required for this metastatic effect. To analyze the functions of the cytoplasmic and extracellular domains of TF in metastasis, two TF mutants were constructed; in one mutant alanine was substituted for each of the three serine residues in the cytoplasmic domain, preventing phosphorylation; in the other mutant alanine was substituted for four key residues in the extracellular domain, preventing binding of factor VIIa and consequently eliminating the initiation of blood coagulation by the TF-VIIa complex. Melanoma lines expressing high levels of either mutant form of TF were weakly metastatic in SCID mice, indicating that phosphorylation of the cytoplasmic domain and formation of a complex with VIIa by the extracellular domain are required for the full metastatic effect of TF. It was also found that increasing TF expression in human melanoma cells does not increase expression of vascular endothelial growth factor or promote growth and vascularization of tumors derived from the melanoma cells, suggesting that TF acts by a mechanism other than angiogenesis to promote metastasis.

 

  • References

  • 1 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8.
    PubMedGoogle Scholar
  • 2 Paborsky LR, Caras IW, Fisher KL, Gorman CM. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J Biol Chem 1991; 266: 21911-6.
    PubMedGoogle Scholar
  • 3 Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92: 8205-9.
    CrossrefPubMedGoogle Scholar
  • 4 Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 1998; 101: 1372-8.
    CrossrefPubMedGoogle Scholar
  • 5 Zioncheck TF, Roy S, Vehar GA. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem 1992; 267: 3561-4.
    PubMedGoogle Scholar
  • 6 Mody RS, Carson SD. Tissue factor cytoplasmic domain peptide is multiple phosphorylated in vitro. Biochem 1997; 36: 7869-75.
    CrossrefPubMedGoogle Scholar
  • 7 Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev 1997; 18: 4-25.
    CrossrefPubMedGoogle Scholar
  • 8 Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320-7.
    CrossrefPubMedGoogle Scholar
  • 9 Toomey JR, Kratzer KE, Lasky NM, Broze Jr GJ. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA 1997; 94: 6922-6.
    CrossrefPubMedGoogle Scholar
  • 10 Kelley RF, Costas KE, O’Connell MP, Lazarus RA. Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding. Biochem 1995; 34: 10383-92.
    CrossrefPubMedGoogle Scholar
  • 11 Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochem 1986; 25: 4007-20.
    CrossrefPubMedGoogle Scholar
  • 12 Hu T, Bach RR, Horton R, Konigsberg WH, Todd MB. Procoagulant activity in cancer cells is dependent on tissue factor expression. Oncology Res 1994; 6: 321-7.
    PubMedGoogle Scholar
  • 13 McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman L, Weissman I L. The SCID-hu mouse: murine model for the analysis of human hemato-lymphoid differentiation and function. Science 1988; 241: 1632-9.
    CrossrefPubMedGoogle Scholar
  • 14 Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, Wilcox JN, Danave I, Dillehay DL, Matthews E, Contrino J, Morrissey JH, Gordon S, Edgington TS, Kudrk B, Kreutzer DL, Rickles FR. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Amer J Pathology 1998; 152: 399-411.
    PubMedGoogle Scholar
  • 15 Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998; 140: 1241-53.
    CrossrefPubMedGoogle Scholar
  • 16 Sundaram R, Konigsberg WH, Bromberg ME, Garen A. unpublished results.
    PubMed
  • 17 Poulsen LK, Jacobsen N, Sorensen BB, Bergenhem NC, Kelly JD, Foster DC, Thasrup O, Ezban M, Petersen LC. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 1998; 273: 6228-32.
    CrossrefPubMedGoogle Scholar
  • 18 Nierodzik ML, Bain RM, Liu LX, Shivji M, Takeshita K, Karpatkin S. Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Brit J of Haematology 1996; 92: 452-7.
    PubMedGoogle Scholar
  • 19 Fischer EG, Ruf W, Mueller BM. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res 1995; 55: 1629.-32.
    PubMedGoogle Scholar